Petco Health & Wellness Company, Inc. (WOOF) Operating Margin
- Operating margin · 12 months: Value 2.24%; Formula and calculation Operating income / revenue. Period ending 2026-08-01..
Operating margin
Overview →Financial period ending 2026-08-01; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 2.24% | Operating income / revenue. Period ending 2026-08-01. $133.49M ÷ $5.97B × 100 ≈ 2.24% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 133.49M USD | Operating Income (Loss) |
| Revenue | 5.97B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 3.65B USD | Cost of Goods and Services Sold |
| Research and development | (m) | |
| Selling, general and administration | 2.18B USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-08-01 | $133.49M | $5.97B | $3.65B | (m) | $2.18B | 2.24% |
| 2026-05-02 | $128.70M | $5.96B | $3.66B | (m) | $2.18B | 2.16% |
| 2026-01-31 | $120.43M | $5.96B | $3.66B | (m) | $2.18B | 2.02% |
| 2025-11-01 | $105.97M | $6.00B | $3.68B | (m) | $2.21B | 1.77% |
| 2025-08-02 | $80.75M | $6.05B | $3.73B | (m) | $2.24B | 1.34% |
| 2025-05-03 | $40.19M | $6.08B | $3.77B | (m) | $2.28B | 0.66% |
| 2025-02-01 | $7.05M | $6.12B | $3.79B | (m) | $2.32B | 0.12% |
| 2024-11-02 | $-10.17M | $6.24B | $3.90B | (m) | $2.35B | -0.16% |
| 2024-08-03 | $-1.25B | $6.22B | $3.91B | (m) | $2.34B | -20.03% |
| 2024-05-04 | $-1.22B | $6.23B | $3.90B | (m) | $2.33B | -19.66% |
| 2024-02-03 | $-1.18B | $6.26B | $3.90B | (m) | $2.31B | -18.87% |
| 2023-10-28 | $-1.10B | $6.16B | $3.78B | (m) | $2.26B | -17.91% |
| 2023-07-29 | $177.27M | $6.17B | $3.74B | (m) | $2.25B | 2.88% |
| 2023-04-29 | $203.24M | $6.12B | $3.69B | (m) | $2.22B | 3.32% |
| 2023-01-28 | $225.56M | $6.04B | $3.61B | (m) | $2.20B | 3.74% |
| 2022-10-29 | $230.90M | $5.97B | $3.54B | (m) | $2.20B | 3.87% |
| 2022-07-30 | $244.80M | $5.91B | $3.48B | (m) | $2.19B | 4.14% |
| 2022-04-30 | $268.26M | $5.87B | $3.43B | (m) | $2.17B | 4.57% |
| 2022-01-29 | $266.07M | $5.81B | $3.38B | (m) | $2.16B | 4.58% |
| 2021-10-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-07-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-05-01 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-01-30 | $194.42M | $4.92B | $2.81B | (m) | $1.91B | 3.95% |
| 2020-10-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-08-01 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-05-02 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-02-01 | $110.60M | $4.43B | $2.53B | (m) | $1.78B | 2.49% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.